Drawing for BACTEROMIC

USPTO serial 79326252

BACTEROMIC

Reviewed by CopyMark Law Group

Reg. 7021154Status 700Registered
Filing date
Status date
Registration date
Apr 11, 2023
Examiner
THOMAS-RIGGS, LESLIE A
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with BACTEROMIC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Otto O. Lee

Otto O. Lee INTELLECTUAL PROPERTY LAW GROUP LLP1871 THE ALAMEDA, SUITE 250San Jose, CA 95126UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic preparations for scientific or research use, other than for medical use; Diagnostic reagents for in-vitro use, other than for medical or veterinary use; Diagnostic reagents for in-vitro use in biochemistry, clinical chemistry and microbiology; Biochemicals for in vitro scientific and research useACTIVE—
005Diagnostic preparations for medical or veterinary use; Diagnostic reagents for medical or veterinary use; Diagnostic testing materials for medical or veterinary use, namely, diagnostic kits consisting primarily of antibiotics or antibiotic compositions for use in phenotypic evaluation of the efficacy of antibiotics used to treat infections, reagents and media for medical and veterinary diagnosis, medical and veterinary assays for determining identity and drug resistance of pathogens; In vitro diagnostic preparations for medical or veterinary use; Reagents for in-vitro use, for medical or veterinary purposesACTIVE—
009Apparatus and instruments for scientific and laboratory research in the field of biochemistry, clinical chemistry and microbiology for research on drug resistance mechanisms, namely, laboratory apparatus and instruments for automated handling of fluid samples, for incubating and culturing microorganisms, for detecting, measuring and analyzing physical or chemical signal, for microbe identification, drug susceptibility testing and research on drug resistance mechanisms, including disposable cartridges, test cards, automated sample transfer devices, analyzers, and recorded software sold as a unit used to process and interpret the signal, diagnostic apparatus and instruments for the detection, quantification, identification and characterization of microorganisms or contaminants, for laboratory or research use; Apparatus and instruments for scientific and laboratory research in the field of biochemistry, clinical chemistry and microbiology for research on antagonism and synergy in the interactions of biologically active substances with microorganisms, namely, apparatus and instruments for phenotypic evaluation of the efficacy of antibiotics and combinations of antibiotics for scientific and research use, research laboratory analyzers, sample transfer devices and test cards for measuring, testing and analyzing environmental samples, biological samples and samples of industrial, agro-foodstuff, cosmetic and pharmaceutical products, laboratory instrument for the detection, identification and/or determination of drug resistance of microorganisms and contaminants in an environmental sample, a biological sample and samples of industrial, agro-foodstuff, cosmetic and pharmaceutical products, automated laboratory equipment for manipulating laboratory samples, and recorded software sold as a unit used to process and interpret the results of the above measurements, tests and analysesACTIVE—
010Diagnostic apparatus for medical or veterinary purposes, namely, diagnostic apparatus for pathogen identification and/or antimicrobial susceptibility testing, medical diagnostic apparatus for testing drug resistance of a pathogen and determining minimum inhibitory concentrations; Automatic analyzers for medical or veterinary diagnosis, namely, automated bacteriologic analyzers, automated microbiologic analyzers, automated antimicrobial susceptibility testing analyzers; Apparatus for carrying-out diagnostic tests for medical or veterinary purposes, namely, medical diagnostic apparatus for identifying pathogens and/or determining their susceptibility to antibiotics or antibiotic compositions; Apparatus used for in-vitro medical or veterinary diagnostics, namely, in-vitro diagnostic systems comprising test cards and automated equipment for manipulating a biological sample of human or animal origin, and for automated testing of the biological sample in-vitro; Analyzers for the identification and determination of drug resistance of bacteria for medical or veterinary purposes; In vitro medical diagnostic kits consisting of an analyzer and disposable cartridges, namely, in vitro diagnostic kits for use in microbial testing; Diagnostic kits for the identification and determination of drug resistance of bacteria for medical or veterinary purposes, consisting of an analyzer and disposable cartridgesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 9, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 4, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 3, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 26, 2023XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Jul 26, 2023XXCRGENERIC MADRID TRANSACTION CREATED—
Jul 11, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 11, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Apr 11, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 4, 2023ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Feb 1, 2023GPNXNOTIFICATION PROCESSED BY IB—
Jan 24, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 24, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 6, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 4, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 4, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 20, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 20, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Dec 20, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 20, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 20, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 2, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 1, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 1, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 22, 2022RFNTREFUSAL PROCESSED BY IB—
Jun 1, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 1, 2022RFRRREFUSAL PROCESSED BY MPU—
Apr 27, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 26, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 19, 2022DOCKASSIGNED TO EXAMINER—
Nov 24, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 20, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 18, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance